CLOBETASOL PROPIONATE 0.05% / NIACINAMIDE 4%- clobetasol propionate 0.05% / niacinamide 4% ointment 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CLOBETASOL PROPIONATE 0.05% / NIACINAMIDE 4%

Directions for use

s

Sincerus Florida, LLC adverse reactions.

o

Active, inactive

d

NDC 72934-5059-3 CLOBETASOL PROPIONATE 0.05% / NIACINAMIDE 4%. Ointment 60gm

s

CLOBETASOL PROPIONATE 0.05% / NIACINAMIDE 4% 
clobetasol propionate 0.05% / niacinamide 4% ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-5059
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
CLOBETASOL PROPIONATE (UNII: 779619577M) (CLOBETASOL - UNII:ADN79D536H) CLOBETASOL PROPIONATE0.05 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-5059-360 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/03/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/03/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-5059)

Revised: 5/2019
Document Id: 87ec3140-f9f4-25d4-e053-2995a90a73c1
Set id: 87ec3140-f9f3-25d4-e053-2995a90a73c1
Version: 1
Effective Time: 20190502
 
Sincerus Florida, LLC